Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Saudi Fund Outpaces Singapore’s GIC With $31.6 Billion Splurge
Saudi Arabia’s Public Investment Fund emerged as the world’s most active sovereign investor last year, boosting its deal activity even as most global peers including GIC Pte and Temasek Holdings Pte slashed spending. PIF, as the Saudi fund is known, deployed $31.6...
Zeus to be acquired by EQT
EQT X fund has entered into an agreement to acquire Zeus from the Tourville family. Founded in 1966, Zeus is a specialist in the design, development, and extrusion of fluoropolymer tubing for medical devices and select industrial applications. EQT also announced that...
Quantum Energy Partners Completes $2.7 Billion Sale of Rockcliff Energy to TG Natural Resources
Quantum Capital Group (“Quantum”) today announced the completion of its previously announced sale of Rockcliff Energy II LLC (“Rockcliff”) to TG Natural Resources LLC (“TGNR”). Rockcliff is a portfolio company of Quantum Energy Partners, Quantum’s private equity...